Accessibility Menu
 
DiaSorin S.p.A. logo

DiaSorin S.p.A.

(OTC) DSRLF

Current Price$70.76
Market Cap$3.82B
Since IPO (2007)+278%
5 Year-55%
1 Year-35%
1 Month-10%

DiaSorin S.p.A. Financials at a Glance

Market Cap

$3.82B

Revenue (TTM)

$1.22B

Net Income (TTM)

$191.51M

EPS (TTM)

$3.75

P/E Ratio

18.32

Dividend

$1.35

Beta (Volatility)

2188.71 (High)

Price

$70.76

Volume

200

Open

$71.57

Previous Close

$70.76

Daily Range

$70.76 - $71.57

52-Week Range

$66.50 - $112.30

DSRLF News

No articles available.

DSRLF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About DiaSorin S.p.A.

Industry

Healthcare Equipment and Supplies

Employees

3,271

CEO

Carlo Rosa

Headquarters

Saluggia, VC 13040, IT

DSRLF Financials

Key Financial Metrics (TTM)

Gross Margin

66%

Operating Margin

36%

Net Income Margin

16%

Return on Equity

12%

Return on Capital

19%

Return on Assets

7%

Earnings Yield

5.46%

Dividend Yield

0.02%

Payout Ratio

64.83%

Stock Overview

Market Cap

$3.82B

Shares Outstanding

53.94M

Volume

200

Short Interest

0.00%

Avg. Volume

22.475

Financials (TTM)

Gross Profit

$781.70M

Operating Income

$258.32M

EBITDA

$399.04M

Operating Cash Flow

$358.78M

Capital Expenditure

$119.72M

Free Cash Flow

$239.07M

Cash & ST Invst.

$344.33M

Total Debt

$1.01B

DiaSorin S.p.A. Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$306.27M

+2.0%

Gross Profit

$201.91M

+2.0%

Gross Margin

65.93%

N/A

Market Cap

$3.82B

N/A

Market Cap/Employee

$1.17M

N/A

Employees

3,249

N/A

Net Income

$47.40M

-5.2%

EBITDA

$94.52M

-7.0%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$594.80M

+26.8%

Accounts Receivable

$208.98M

+7.0%

Inventory

$327.98M

+0.1%

Long Term Debt

$531.28M

-45.2%

Short Term Debt

$237.91M

+299.1%

Return on Assets

6.68%

N/A

Return on Invested Capital

18.88%

N/A

Free Cash Flow

$48.30M

-12.1%

Operating Cash Flow

$73.96M

-7.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
FLMNFFielmann AG
$52.85+0.00%
GNGBYGetinge AB (publ)
$18.99-3.41%
CNVVYConvaTec Group Plc
$11.72-6.39%
GZPHFGuangzhou Baiyunshan Pharmaceutical Holdings Company Limited
$2.34-8.55%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$43.87-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
RITMRithm Capital
$8.77-0.03%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%

Questions About DSRLF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.